癌症診斷市場規模、佔有率、成長分析（按產品、技術、應用、最終用戶、地區）- 2025 年至 2032 年產業預測

2023 年癌症診斷市場規模價值 1,100 億美元，預計將從 2024 年的 1,196.8 億美元成長到 2032 年的 2,349.9 億美元，預測期內（2025-2032 年）的複合年成長率為 8.8%。

由於全球癌症病例不斷增加，預計未來幾年對癌症診斷藥物的需求將大幅增加。市場成長的關鍵驅動力包括對腫瘤學研究的大量投資以及對癌症早期發現的日益關注，從而改善治療效果。此外，人們對各種癌症類型的認知不斷提高以及診斷技術的創新預計將進一步推動需求。此外，向標靶治療和個人化醫療的轉變也將推動先進診斷工具的使用。然而，高成本、誤報風險和訪問受限等挑戰可能會限制這段時期及以後的市場潛力。總體而言，癌症診斷市場預計將在這些不斷變化的動態中經歷顯著成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 專利分析
• 監管分析
• 技術分析
• 案例研究

癌症診斷市場規模（按產品和複合年成長率） (2025-2032)

• 市場概覽
• 耗材
  • 抗體
  • 套件和試劑
  • 探測
  • 其他耗材
• 裝置
  • 基於病理學的儀器
  • 玻片染色系統
  • 組織處理系統
  • 細胞處理器
  • PCR設備
  • NGS設備
  • 微陣列
  • 其他基於病理學的儀器
  • 影像設備
  • CT系統
  • 超音波系統
  • MRI系統
  • 乳房X光攝影系統
  • 核子造影系統
  • 切片檢查器械

癌症診斷市場規模（依技術及複合年成長率） (2025-2032)

• 市場概覽
• 體外診斷測試
  • 聚合酵素鏈鎖反應
  • 原位雜合技術
  • 免疫組織化學
  • 次世代定序
  • 免疫檢測
  • 微陣列
  • 流式細胞技術
  • 其他 IVD 技術
• 影像技術
  • 磁振造影
  • 電腦斷層掃描
  • 核子造影
  • 乳房X光檢查
  • 超音波
• 切片檢查

癌症診斷市場規模（按應用）及複合年成長率（2025-2032）

• 市場概覽
• 乳癌
• 肺癌
• 大腸直腸癌
• 黑色素瘤
• 其他癌症

癌症診斷市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 醫院
• 診斷實驗室

癌症診斷市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Abbott Laboratories（US）
• Becton, Dickinson and Company（BD）（US）
• bioMerieux SA（France）
• Danaher Corporation（US）
• Hoffmann-La Roche Ltd.（Switzerland）
• GE Healthcare（US）
• Hologic, Inc.（US）
• Illumina, Inc.（US）
• Koninklijke Philips NV（Netherlands）
• Merck KGaA（Germany）
• Myriad Genetics, Inc.（US）
• QIAGEN NV（Netherlands）
• Siemens Healthineers AG（Germany）
• Sysmex Corporation（Japan）
• Thermo Fisher Scientific Inc.（US）
• Exact Sciences Corporation（US）
• Guardant Health, Inc.（US）
• Caris Life Sciences（US）

結論和建議

Cancer Diagnostics Market size was valued at USD 110.0 billion in 2023 and is poised to grow from USD 119.68 billion in 2024 to USD 234.99 billion by 2032, growing at a CAGR of 8.8% during the forecast period (2025-2032).

The global rise in cancer incidences is set to significantly enhance the demand for cancer diagnostics in the coming years. Key drivers for market growth include substantial investments in oncology research and an increasing focus on early cancer detection, which can lead to improved treatment outcomes. Additionally, heightened awareness of various cancer types and innovations in diagnostic technologies are expected to further boost demand. The shift towards targeted therapies and personalized medicine will also propel the use of advanced diagnostic tools. However, challenges such as high costs, the risk of false positives, and restricted access may limit market potential throughout this period and beyond. Overall, the cancer diagnostics market is poised for substantial growth amidst these evolving dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cancer Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cancer Diagnostics Market Segments Analysis

Global Cancer Diagnostics Market is segmented by Product, Technology, Application, End User and region. Based on Product, the market is segmented into Consumables and Instruments. Based on Technology, the market is segmented into IVD Testing, Imaging Technologies and Biopsies. Based on Application, the market is segmented into Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma and Other Cancers. Based on End User, the market is segmented into Hospitals and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cancer Diagnostics Market

The rising prevalence of cancer has become a pressing issue globally, largely driven by poor lifestyle choices and the widespread adoption of unhealthy habits. This increase in cancer incidence is a major catalyst for the growing demand for cancer diagnostics. As more individuals are diagnosed with various types of cancer, there is an urgent need for effective diagnostic tools and services to support early detection and treatment. Consequently, the cancer diagnostics market is experiencing significant growth, addressing the critical need for timely and accurate diagnosis, thus ultimately improving patient outcomes and advancing healthcare solutions in this vital area.

Restraints in the Cancer Diagnostics Market

The Cancer Diagnostics market faces significant restraints, particularly in underdeveloped and developing nations that are still striving to enhance their healthcare infrastructure. In these regions, healthcare facilities often operate with constrained budgets, limiting their ability to invest in advanced diagnostic technologies. As a result, access to innovative diagnostic procedures is significantly hampered, hindering the identification and treatment of cancer. This lack of financial resources restricts the adoption of state-of-the-art diagnostic devices, ultimately impacting the overall effectiveness and progression of cancer diagnosis in these markets. Consequently, this limitation poses a notable challenge to the growth of the Cancer Diagnostics industry globally.

Market Trends of the Cancer Diagnostics Market

The Cancer Diagnostics market is witnessing a significant trend toward the integration of artificial intelligence (AI) technologies, poised to revolutionize traditional diagnostic methods. Companies are increasingly leveraging AI in diagnostic imaging, enhancing accuracy and efficiency in identifying malignancies at earlier stages. This innovation not only streamlines the diagnostic process but also presents new business opportunities for companies specializing in cancer detection. By harnessing the power of AI, firms can improve patient outcomes, reduce diagnostic errors, and optimize resource allocation. As the demand for precise and rapid cancer diagnostics grows, the successful adoption of AI will be a critical differentiator in a competitive landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies

Global Cancer Diagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Consumables
  • Antibodies
  • Kits & Reagents
  • Probes
  • Other Consumables
• Instruments
  • Pathology-Based Instruments
  • Slide staining systems
  • Tissue processing systems
  • Cell processors
  • PCR instruments
  • NGS instruments
  • Microarrays
  • Other pathology-based instruments
  • Imaging Instruments
  • CT systems
  • Ultrasound systems
  • MRI systems
  • Mammography systems
  • Nuclear imaging systems
  • Biopsy Instruments

Global Cancer Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• IVD Testing
  • Polymerase Chain Reaction
  • In Situ Hybridization
  • Immunohistochemistry
  • Next-Generation Sequencing
  • Immunoassay
  • Microarray
  • Flow Cytometry
  • Other IVD Technologies
• Imaging Technologies
  • Magnetic Resonance Imaging
  • Computed Tomography
  • Nuclear Imaging
  • Mammography
  • Ultrasound
• Biopsies

Global Cancer Diagnostics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Melanoma
• Other Cancers

Global Cancer Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Laboratories

Global Cancer Diagnostics Market Size & CAGR (2025-2032)

• North America (Product, Technology, Application, End User)
  • US
  • Canada
• Europe (Product, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exact Sciences Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guardant Health, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caris Life Sciences (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations